Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
62 hedge funds and large institutions have $33.4M invested in Checkpoint Therapeutics in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 14 closing their positions.
157% more call options, than puts
Call options by funds: $782K | Put options by funds: $304K
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
0% more ownership
Funds ownership: 1.4% → 1.4% (+0%)
4% less capital invested
Capital invested by funds: $34.7M → $33.4M (-$1.29M)
7% less funds holding
Funds holding: 67 → 62 (-5)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.59M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$889K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$823K |
| 4 |
Renaissance Technologies
New York
|
+$750K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$682K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$989K |
| 2 |
Two Sigma Advisers
New York
|
-$506K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$402K |
| 4 |
AMC
Asset Management Corp
Northbrook,
Illinois
|
-$283K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$270K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Group One Trading
Chicago,
Illinois
| – | -$331 | -10 | Closed |
|
CKPT Hedge Fund Activity: Q4 2021 in Review
62 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q4 2021, worth a combined $33.4M — down 3.7% from $34.7M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CKPT and 12 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 16 added.
The largest buyer was Susquehanna International Group, adding an estimated $1.59M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $989K sold.
- 62 institutional investors held Checkpoint Therapeutics (CKPT) as of Q4 2021, down from 67 in Q3 2021.
- Funds reported $33.4M of Checkpoint Therapeutics stock for Q4 2021, down 3.7% quarter-over-quarter.
- 12 funds opened new Checkpoint Therapeutics positions in Q4 2021 and 14 closed out, a net change of -2 holders.
- The largest Checkpoint Therapeutics buyer in Q4 2021 was Susquehanna International Group, an estimated $1.59M added.
- The largest Checkpoint Therapeutics seller in Q4 2021 was Two Sigma Investments, an estimated $989K sold.
Based on aggregated 13F filings for Q4 2021.